EXPLORE MORE CATEGORIES
- Home
- ยป
- What We Offer
- »
- Tabletes I
Tabletes I
Our range of products include tykerb tablet, taxotere tablet and uromitexan tablet.
Tykerb Tablet
Get Latest Price
Product Details:
| Packaging Size | 250 mg |
| Packaging Type | Sachet |
| Form | Tablet |
| Material | TYKERB |
| Usage | Clinical |
| Grade | Medicine grade |
"Lapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It is present as the monohydrate of the ditosylate salt, with chemical name N-(3- chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine bis(4- methylbenzenesulfonate) monohydrate. It has the molecular formula C29H26ClFN4O4S (C7H8O3S)2 H2O and a molecular weight of 943.5. Lapatinib ditosylate monohydrate has the following chemical structure: TYKERB (lapatinib) Structural Formula Illustration Lapatinib is a yellow solid, and its solubility in water is 0.007 mg/mL and in 0.1N HCl is 0.001 mg/mL at 25°C. Each 250 mg tablet of TYKERB contains 405 mg of lapatinib ditosylate monohydrate, equivalent to 398 mg of lapatinib ditosylate or 250 mg lapatinib free base. The inactive ingredients of TYKERB are: Tablet Core: Magnesium stearate, microcrystalline cellulose, povidone, sodium starch glycolate. Coating: Orange film-coat: FD&C yellow No. 6/sunset yellow FCF aluminum lake, hypromellose, macrogol/PEG 400, polysorbate 80, titanium dioxid"
ONCOLOGY
Get Best QuoteRequest A Callback
Taxotere Tablet
Get Latest Price
Product Details:
| Type Of Medicines | Allopathic |
| Application | Anti Infective And Common Disease Medicines |
| Dose | <100 mg |
| Packaging Type | Sachet |
| Usage | Clinical, Hospital |
| Packaging size | 10 x 10 |
Get Best QuoteRequest A Callback
Uromitexan Tablet
Get Latest Price
BAXTER ONCOLOGY
"Uromitexan (mesna) New Zealand Data Sheet Uromitexan Data Sheet 7 August 2014 Page 1 of 14 Baxter UROMITEXAN Mesna 400mg tablets and 600mg film coated tablet Active ingredient:
mesna Inactive ingredients: calcium hydrogen phosphate, lactos e monohydrate, starch-maize,
cellulose microcrystalline, povidone, magnesium stearate. Coating: hypromellose, Macrogol 6000, simethicone, titanium dioxide. Molecular formula: C2H5NaO3S2 with a molecular weight of 164.18. Structural formula: HS-CH 2 -CH 2-SO3Na+DESCRIPTION The active ingredient, mesna, is a synthetic sulphydryl compound designated as sodium 2- mercapto-ethane sulphonate.
Uromitexan tablets are white oblong, biconvexfilm-coated tablets, scored on one side and marked “M 4” or “M 6”, containing 400mg or 600mg (respectively) of mesna"
ONCOLOGY
"Uromitexan (mesna) New Zealand Data Sheet Uromitexan Data Sheet 7 August 2014 Page 1 of 14 Baxter UROMITEXAN Mesna 400mg tablets and 600mg film coated tablet Active ingredient:
mesna Inactive ingredients: calcium hydrogen phosphate, lactos e monohydrate, starch-maize,
cellulose microcrystalline, povidone, magnesium stearate. Coating: hypromellose, Macrogol 6000, simethicone, titanium dioxide. Molecular formula: C2H5NaO3S2 with a molecular weight of 164.18. Structural formula: HS-CH 2 -CH 2-SO3Na+DESCRIPTION The active ingredient, mesna, is a synthetic sulphydryl compound designated as sodium 2- mercapto-ethane sulphonate.
Uromitexan tablets are white oblong, biconvexfilm-coated tablets, scored on one side and marked “M 4” or “M 6”, containing 400mg or 600mg (respectively) of mesna"
ONCOLOGY
Get Best QuoteRequest A Callback